Device Access UK Ltd's Podcast

As NHS waiting lists grow, the need for operational gains intensifies. Hospitals need to be able to make faster diagnoses and deliver more efficient treatments to free up bed space and admit more patients. The issue is not simply about the NHS working harder, but working smarter, and this is where MedTech can help.This podcast will delve into the ways in which MedTech can support hospitals as a whole, rather than just individual patients or clinicians. The panellists will also be discussing how MedTech companies can utilise this in selling their own products.

The NHS's target is to become the world's first 'net zero' national health service. Their ambitious plan shows that the greatest areas of opportunity are in the supply chain, estates and facilities, pharmaceuticals and medical devices, and travel.What does this mean for the MedTech industry and what do you need to prepare for?

Michael Branagan-Harris is joined by John West and Emily Arbuthnot to discuss the mounting pressure on the NHS. The session covers everything from waiting lists to how to engage with healthcare professionals to expedite your journey into the NHS. 

This episode is also available on Youtube, simply search for Device Access to find our channel. 

This webinar featured an impressive group of panellists, including:-Michael Branagan-Harris, CEO, Device Access-James Lindley, Commercial Counselor, US Embassy London-Jeff Dillon, UK Dept International Trade DIT-Amit Kukreja, Vice President | Corporate Market Access & Reimbursement at MasimoFormer Vice President, Global Marketing, Reimbursement and Patient Access at Second Sight Medica. Products-Dawn Smiles, Founder and Clinical Director at MedTec Consulting Ltd-Michael Kujak, Former Chief Marketing Officer & SVP International Commercialization NxThera Inc-John West, Director, Pellere Health

This episode is also available on Youtube, simply search for Device Access to find our page. 

Our panellists are:Michael Branagan-Harris - CEO, Device Access UKMattias Kyhlstedt - CEO, SynergusProfessor Tom Clutton-Brock FRCP, FRCA, FFICM- Director, Medical Devices Testing and Evaluation Centre & Chair, NICE Interventional Procedures Advisory CommitteeDr Peter Walton - Managing Director, Dendrite Clinical Systems

Michael Branagan-Harris (CEO of Device Access) will be joined by Bruce Robinson, an expert in private hospital reimbursement. Bruce has worked for various private groups including BUPA, BMI Healthcare and Nuffield Health.

Mike is joined by the patient voice advocators at MediPace, MedTech PR specialist Amanda Hayhurst and Si Bone founder Richard Moss, who shares how his technology was adopted into the NHS. 

Michael Branagan-Harris is joined by a panel of experts again, discussing how to expedite your journey into the NHS.  

In this webinar, we were joined by MedTech innovators and investors to discuss how to reduce risk by understanding the principles of Market Access. 

Michael Branagan-Harris is joined by professionals from within the NHS, the digital marketing industry and a medtech innovator. 

Considering getting NHS England to support the adoption and diffusion of your product? Listen to find out more from the experts on the NICE MedTech team on evidence requirements, as well as NHS Hospital Clinical Management on how NICE approval speeds hospital buying decisions.  

Join Mike as he talks to top figures in the NHS to discuss the re-opening of elective surgery post covid-19.Device Access UK is a market access company that assists in getting great technologies to patients faster. 

CEO of Device Access UK, Michael Branagan-Harris gathers a panel of NHS management to discuss the future of MedTech Engagement with the NHS in the wake of Covid-19 and how best to approach it. Device Access UK helps MedTech companies all over the world demonstrate the true value of their device, to help in getting great technologies to patients faster.